Cite
HARVARD Citation
Johanna, I. et al. (2019). Evaluating in vivo efficacy – toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells. Journal for immunotherapy of cancer. 7 (1), p. . [Online].